<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05127642</url>
  </required_header>
  <id_info>
    <org_study_id>HAOPPHCUSS</org_study_id>
    <nct_id>NCT05127642</nct_id>
  </id_info>
  <brief_title>Hemostatic Assessment of Postpartum Hemorrhage Using Sonoclot Signature</brief_title>
  <official_title>Hemostatic Assessment of Postpartum Hemorrhage Cases Using Sonoclot Signature</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postpartum hemorrhage is the leading cause of maternal morbidity and mortality throughout the&#xD;
      world. Rapid diagnosis and early management improve maternal prognosis.&#xD;
&#xD;
      Postpartum hemorrhage is defined by a blood loss exceeding 500 ml during the 24 h after&#xD;
      delivery.&#xD;
&#xD;
      There are many causes of postpartum hemorrhage. Most cases develop from uterine atony, which&#xD;
      accounts for 75% of cases. Even though there are risk factors for postpartum hemorrhage, it&#xD;
      is still an unpredictable obstetric emergency.&#xD;
&#xD;
      Coagulation plays an important role in postpartum hemostasis. Primary and especially&#xD;
      secondary coagulation disorders are risk factors for Postpartum hemorrhage.&#xD;
&#xD;
      When bleeding occurs, the decrease in fibrinogen levels is the most rapid change observed&#xD;
      among markers of coagulation. Recent studies show that fibrinogen concentration during the&#xD;
      initial management of Postpartum hemorrhage is the most informative biological marker for the&#xD;
      severity of the hemorrhage.&#xD;
&#xD;
      Various methods are used to record coagulation profile. One of them is estimation by&#xD;
      sonoclot.&#xD;
&#xD;
      Viscoelastic hemostatic assays devices (such as sonoclot) have practical advantages as&#xD;
      point-of-care devices for monitoring major hemorrhage including a set of parameters that&#xD;
      assesses a global coagulation profile like fibrinogen and platelet count.&#xD;
&#xD;
      Identification of coagulopathy by viscoelastic point-of-care testing can be helpful in&#xD;
      guiding management of Postpartum hemorrhage and preventing severe maternal outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Haemostatic assessment in Postpartum haemorrhage Patients using Sonoclot signature.</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Postpartum Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Postpartum hemorrhage patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls (non postpartum hemorrhage patients)</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be conducted in Assiut University Hospital, both clinical pathology&#xD;
        department and obstetric and gynaecological department.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. patients in childbearing period.&#xD;
&#xD;
          2. Patients with bleeding occurring in the first 24 hours after delivery (primary&#xD;
             postpartum hemorrhage).&#xD;
&#xD;
          3. Patients with causes of Postpartum hemorrhage like uterine atony, preeclampsia, blood&#xD;
             diseases as inherited and prepartum acquired coagulopathies, and others e.g., acute&#xD;
             fatty liver of pregnancy, amniotic fluid embolism, etc.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with bleeding after 24 hours from delivery (secondary postpartum hemorrhage).&#xD;
&#xD;
          2. Patients with miscarriages (bleeding before 22 weeks of gestation) or Antepartum&#xD;
             hemorrhage.&#xD;
&#xD;
          3. Traumatic causes of postpartum hemorrhage e.g., rupture uterus, abruptio placenta,&#xD;
             Lacerations, hematomas, Uterine inversion, and iatrogenic trauma.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rehab A.Mohammed Omran</last_name>
    <phone>01025113833</phone>
    <email>Remy25.1994rn@gmail.com</email>
  </overall_contact>
  <results_reference>
    <citation>Liew-Spilger AE, Sorg NR, Brenner TJ, Langford JH, Berquist M, Mark NM, Moore SH, Mark J, Baumgartner S, Abernathy MP. Viscoelastic Hemostatic Assays for Postpartum Hemorrhage. J Clin Med. 2021 Aug 31;10(17). pii: 3946. doi: 10.3390/jcm10173946. Review.</citation>
    <PMID>34501395</PMID>
  </results_reference>
  <results_reference>
    <citation>Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, Rudigoz RC. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG. 2009 Jul;116(8):1097-102. doi: 10.1111/j.1471-0528.2009.02187.x. Epub 2009 May 12.</citation>
    <PMID>19459866</PMID>
  </results_reference>
  <results_reference>
    <citation>Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018 Apr 25;4:CD011689. doi: 10.1002/14651858.CD011689.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Dec 19;12:CD011689.</citation>
    <PMID>29693726</PMID>
  </results_reference>
  <results_reference>
    <citation>Henriquez DDCA, Bloemenkamp KWM, van der Bom JG. Management of postpartum hemorrhage: how to improve maternal outcomes? J Thromb Haemost. 2018 Jun 8. doi: 10.1111/jth.14200. [Epub ahead of print] Review.</citation>
    <PMID>29883040</PMID>
  </results_reference>
  <results_reference>
    <citation>Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012 Jun;108(6):984-9. doi: 10.1093/bja/aes096. Epub 2012 Apr 6.</citation>
    <PMID>22490316</PMID>
  </results_reference>
  <results_reference>
    <citation>Benes J, Zatloukal J, Kletecka J. Viscoelastic Methods of Blood Clotting Assessment - A Multidisciplinary Review. Front Med (Lausanne). 2015 Sep 14;2:62. doi: 10.3389/fmed.2015.00062. eCollection 2015. Review.</citation>
    <PMID>26442265</PMID>
  </results_reference>
  <results_reference>
    <citation>Curry NS, Davenport R, Pavord S, Mallett SV, Kitchen D, Klein AA, Maybury H, Collins PW, Laffan M. The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline. Br J Haematol. 2018 Sep;182(6):789-806. doi: 10.1111/bjh.15524. Epub 2018 Aug 2.</citation>
    <PMID>30073664</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Rehab Abdelnasser Mohammed Omran</investigator_full_name>
    <investigator_title>resident doctor, clinical Pathology department.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postpartum Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

